1967 Buick Special on 2040-cars

Auto blog

GM expanding Lansing Lambda CUV plant

Considering that crossovers are a rapidly growing portion of the US auto market, it's not surprising to hear that General Motors is preparing to build even more of them. The company is investing $63 million to expand its Lansing Delta Township Assembly plant that builds Lambda platform CUVs like the Chevrolet Traverse, GMC Acadia and Buick Enclave.
According to GM, the expansion will add roughly 263,000 extra square feet of space to the plant. Of that, 181,000 square feet will be for an updated body shop with cutting-edge robots. There will also be 54,000 square feet of additional room in the paint shop and 28,000 square feet of more area for general assembly.
GM isn't saying as much, but there is the possibility that this extra space could allow for additional models produced at the factory. Cadillac reportedly dropped plans to build a three-row SUV on the Lambda platform earlier this year, however, dealers for the luxury brand were recently pitched the possibility of adding large and small CUVs, an ATS convertible or a sedan below the ATS.

GM seeks to exempt Buick Envision from U.S. auto tariffs

General Motors is seeking an exemption to a 25 percent U.S. tariff on its Chinese-made Buick Envision sport utility, the automaker said on Thursday, in a move to prevent the key model in the brand's U.S. lineup from becoming a victim of the U.S.-China trade war. The midsize SUV, priced starting at about $35,000, has become a target for critics of Chinese-made goods, including leaders of the United Auto Workers union and members in key political swing states such as Michigan and Ohio. The Envision, assembled only in China, last year accounted for about 19 percent of Buick brand sales in the United States. GM said in a statement that it filed the request on July 30 with the U.S. Trade Representative. An official notice was posted on Thursday on the regulations.gov website, which is tracking requests for exclusions from the so-called Section 301 tariff on certain imported goods from China. GM, the largest U.S. automaker, argued in its request that Envision sales in China and the United States would generate funds "to invest in our U.S. manufacturing facilities and to develop the next generation of automotive technology in the United States." GM said the "vast majority" of Envisions, about 200,000 a year, are sold in China. About 41,000 were sold last year in the United States. Because of the lower U.S. sales volume, "assembly in our home market is not an option" for the Envision, which competes with such midsize crossover vehicles as the Jeep Grand Cherokee and the Cadillac XT5. GM has taken other steps to soften the blow of tariffs, which hit just as the automaker had lowered the price of the Envision to make it more competitive. Ahead of the July 6 start for higher import tariffs, GM shipped in a six-month supply of Envisions at the much lower 2.5 percent tariff rate. Envision sales from April through June plunged to just 7,000 vehicles, while inventories climbed to more than 13,000 vehicles at the end of June. At the current sales rate, the Envision supply should be enough to keep many dealers stocked through the end of the year. GM had lowered prices by as much as $2,500 on the 2019 models, which it started shipping in late April. That means Buick's 2,000 U.S. dealers should have lower-priced Envisions to sell well into the fall. "The previous price point was too high" on the 2018 Envision, said Casey Clark, sales manager at Serra Buick GMC Cadillac in Washington, Michigan, in an interview.

2013 Buick Encore

City, Slicker
We admit it. We have no earthly idea how this whole thing is going to shake out.
Typically, after driving a new car or truck, we come away prepared to hazard a guess as to whether said model has a good chance of being a sales success. We've amassed enough time watching the industry, scrutinizing the competitors, and so on, to make a reasonably educated bet. Yet here we are, days removed from driving the new 2013 Buick Encore, and we still have no bloody idea.